Stock GLTO GALECTO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Galecto, Inc.

Equities

GLTO

US36322Q1076

Delayed Nasdaq
Other stock markets
 01:21:19 01/05/2024 am IST 		5-day change 1st Jan Change
0.6755 USD -3.73% Intraday chart for Galecto, Inc. -3.58% -6.18%
08/03 Galecto, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Galecto Shares Climb After Bone Marrow Disease Treatment Trial Yields Positive Results MT

Chart calendar Galecto, Inc.

67293e65cb863f83b.kI5Zjl2fOZkR6984nJdec0xKvC0tkUu9kuNQU_Drpdo.pdcVzxLJatpCm5dc0KckNAou7EEZojHt0bdlNJK7kOLzuG7dNdNIzTyZtA~d29ead499039766a5b3667782017b53a

Upcoming events on Galecto, Inc.

31/07/2024 Q2 2024 Earnings Release (Projected)

Past events on Galecto, Inc.

26/04/2024 Q1 2024 Earnings Release (Projected)
28/09/2023 02:15 am Cantor Global Healthcare Conference
11/09/2023 04:30 pm H.C. Wainwright Global Investment Conference
01/08/2023 01:35 am Q2 2023 Earnings Release
14/06/2023 06:30 pm Annual General Meeting
09/06/2023 01:30 am Jefferies Global Healthcare Conference
21/05/2023 06:30 pm ATS International Conference - Session: A67
28/04/2023 05:30 pm Q1 2023 Earnings Release
18/04/2023 06:30 pm American Association for Cancer Research Meeting - Abstract Number:LB173
17/04/2023 06:30 pm American Association for Cancer Research Meeting - Abstract Number:LB104
13/03/2023 06:50 pm Oppenheimer Healthcare Conference
09/03/2023 05:30 pm Q4 2022 Earnings Release
14/02/2023 06:30 pm SVB Securities Global Biopharma Conference
11/12/2022 05:00 am American Society of Hematology Meeting
16/11/2022 12:55 pm Jefferies London Healthcare Conference
08/11/2022 09:00 pm American Association for the Study of Liver Diseases Meeting - Abstract Number:5014
08/11/2022 07:45 pm Q3 2022 Earnings Release
08/11/2022 06:30 pm Guliver-2 Phase 1b/2a Results Call
07/11/2022 11:30 pm American Association for the Study of Liver Diseases Meeting - Abstract Number:38895
06/11/2022 11:30 pm American Association for the Study of Liver Diseases Meeting - Abstract Number:3627

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00


-33,4
-40,3
16.98%		-51,8
-54,3
4.66%		-60,7
-66,6
8.9%		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-39,0


-33,6
-38,4
12.41%		-52,2
-54,2
3.62%		-61,2
-66,7
8.21%		-39,9
-40,3
1.06%
-34,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-34,8
-38,3
9.04%		-51,8
-53,3
2.9%		-61,6
-66,0
6.63%		-38,3
-38,5
0.47%
-33,7

Net income
Million USD		Released
Forecast
Spread 		0,00


-34,8
-40,6
14.27%		-51,8
-53,6
3.51%		-61,6
-64,5
4.53%		-38,3
-40,0
4.04%
-32,7

EPS
USD		Released
Forecast
Spread 		-421


-7,62
-5,10
-49.51%		-2,05
-2,13
3.76%		-2,43
-2,51
3.19%		-1,44
-1,51
4.64%
-1,20

Announcement Date02/09/2029/03/2117/02/2209/03/2308/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
-


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00

EBITDA
Million USD		Released
Forecast
Spread











-13,4
-18,4
27.43%























EBIT
Million USD		Released
Forecast
Spread 		-13,5
-14,6
7.75%


-17,1
-13,8
-24.25%		-13,6
-16,9
19.35%		-13,5
-18,4
26.61%		-13,5
-17,7
23.77%		-11,2
-14,9
24.86%		-5,86
-13,3
56.08%		-6,67
-7,10
6.02%











Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-13,4
-14,3
6.23%











-13,0
-17,7
26.59%		-10,7
-14,9
27.65%		-8,14
-13,1
38.06%		-6,48
-6,66
2.72%











Net income
Million USD		Released
Forecast
Spread 		-13,4
-14,3
6.23%		-16,9


-16,9
-17,3
2.39%		-13,7
-17,3
20.64%		-14,1
-14,5
2.97%		-13,0
-16,1
19.04%		-10,7
-14,9
27.65%		-8,14
-12,7
36.06%		-6,48
-8,42
23.09%		-5,48
-11,3
51.53%
-10,5


-4,80


-4,30

EPS
USD		Released
Forecast
Spread 		-0,53
-0,56
5.36%		-0,67


-0,67
-0,69
2.9%		-0,54
-0,68
20.59%		-0,55
-0,57
3.51%		-0,51
-0,63
18.4%		-0,41
-0,59
30.11%		-0,30
-0,47
36.17%		-0,23
-0,31
25.81%		-0,20
-0,29
31.03%
-0,25


-0,14


-0,12

Announcement Date17/02/2229/04/2229/07/2208/11/2209/03/2328/04/2331/07/2306/11/2308/03/2429/04/24---

Upcoming sector events for Galecto, Inc.

01/05/2024 SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
01/05/2024 MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024 04:30 pm NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release
02/05/2024 01:35 am SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release
02/05/2024 ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
02/05/2024 DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
02/05/2024 GERON CORPORATION: Q1 2024 Earnings Release
02/05/2024 KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
More events

Past sector events for Galecto, Inc.

Today 01:35 am EXELIXIS, INC.: Q1 2024 Earnings Release
Today DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
Today ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
Today MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
29/04/2024 04:30 pm WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
29/04/2024 INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release
29/04/2024 HITGEN INC.: Q1 2024 Earnings Release (Projected)
29/04/2024 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release (Projected)
28/04/2024 SHANGHAI MEDICILON INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. GLTO Stock
  4. Calendar Galecto, Inc.